ENDURO Trial Results, EASL Hepatitis B Guidelines 2025, AI in Endoscopy & IBS Biomarkers | Latest GI Updates
Update: 2025-10-06
Description
In this episode, we cover five crucial updates shaping gastroenterology and endoscopy practice in 2025. From the practice-changing ENDURO trial comparing endoscopic to surgical approaches for malignant gastric outlet obstruction, to the latest EASL hepatitis B management guidelines, AI applications in endoscopy, sedation innovations, and biomarker-driven approaches to IBS.
Resources & Links
ENDURO Trial & EUS-Guided Gastroenterostomy
- ENDURO Study Protocol - Trials Journal
- ENDURO Trial Results - The Lancet Gastroenterology & Hepatology
- EUS-GE Overview - Gastroenterology & Endoscopy News
- Prospective Study - Gastrointestinal Endoscopy
EASL 2025 Hepatitis B Guidelines
- EASL HBV Guidelines 2025 - Journal of Hepatology
- EASL Guidelines Summary - EASL Website
- HBV Guidelines PDF - Hepatitis B Foundation
AI in Endoscopy
- AI and Polyp Detection Review - PMC
- AI-Assisted Colonoscopy Meta-Analysis - Annals of Internal Medicine
- Use of AI in Colonoscopy - Gastrointestinal Endoscopy
- Endoscopist Deskilling Study - The Lancet
- Bibliometric Analysis - Frontiers in Medicine
Sedation Innovations
- Remimazolam Review - Clinical Endoscopy
- Remimazolam vs Propofol Meta-Analysis - British Journal of Anaesthesia
- Remimazolam Comprehensive Review - World Journal of GI Endoscopy
- Remimazolam Real-World Study - BMC Gastroenterology
- Safety and Efficacy Comparison - BMC Anesthesiology
IBS Biomarkers & Microbiome
- 2025 Seoul Consensus on IBS - PMC
- 16S rRNA Microbiome Biomarkers for IBS - PMC
- International Consensus on Microbiome Testing - Gut Microbiota for Health
- Gut Microbiome Resilience Review - Frontiers in Microbiology
This podcast is for educational purposes only and does not constitute medical advice. Always consult current guidelines and use clinical judgment when making treatment decisions.
Comments
In Channel